Arthur Ribeiro Cenci

Arthur Ribeiro Cenci

Auto-generated profile, based on publicly available information

Arthur Ribeiro Cenci

Department of Exact Sciences and Education, Federal University of Santa Catarina, Blumenau-SC, Brazil

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2024 in Current Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
AOAldo Oliveira
Aldo Oliveira
ACArthur R. Cenci
Arthur R. Cenci
LGLucas Gonçalves
Lucas Gonçalves
MTMaria Eduarda C. Thedy
Maria Eduarda C. Thedy
AJAngelica Justino
Angelica Justino
LMLidiane Meier
Lidiane Meier
Background: The indiscriminate use of antibiotics brings an alarming reality: in 2050, bacterial resistance could be the main cause of death in the world, resulting in the death of 10 million people, according to the World Health Organization (WHO). In this sense, to combat bacterial resistance, several natural substances, including chalcones, have been described in relation to antibacterial, representing a potential tool for the discovery of new antibacterial drugs. Objective: The objective of this study is to perform a bibliographic survey and discuss the main contributions in the literature about the antibacterial potential of chalcones in the last 5 years. Methods: A search was carried out in the main repositories, for which the publications of the last 5 years were investigated and discussed. Unprecedented in this review, in addition to the bibliographic survey, molecular docking studies were carried out to exemplify the applicability of using one of the molecular targets for the design of new entities with antibacterial activity. Results: In the last 5 years, antibacterial activities were reported for several types of chalcones, for which activities were observed for both gram-positive and gram-negative bacteria with high potency, including MIC values in the nanomolar range. Molecular docking simulations demonstrated important intermolecular interactions between chalcones and residues from the enzymatic cavity of the enzyme DNA gyrase, one of the validated molecular targets in the development of new antibacterial agents. Conclusion: The data presented demonstrate the potential of using chalcones in drug development programs with antibacterial properties, which may be useful to combat resistance, a worldwide public health problem.

18 October 2022 in RSC Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
VMValkiria Machado
Valkiria Machado
ACArthur R. Cenci
Arthur R. Cenci
KTKerolain F. Teixeira
Kerolain F. Teixeira
LSLarissa Sens
Larissa Sens
Tiago TizzianiTiago Tizziani
Tiago Tizziani
AOAldo Oliveira
Aldo Oliveira
Alzheimer's disease (AD) is a neurodegenerative disease that is characterized as the main dementia in the elderly. Eighteen pyrazolines were synthesized and evaluated for their inhibitory effects against acetylcholinesterase (AChE) in vitro. Possible interactions between pyrazolines and the enzyme were explored by in silico experiments. Compound 2B of the series was the most active pyrazoline with an IC50 value of 58 nM. Molecular docking studies revealed two important π–π interactions with residues Trp 286 and Tyr 341. A correlation between the HOMO-1 surface and AChE inhibition was observed. ADMET assays demonstrated a good profile for compound 2B. From the abovementioned findings, a new avenue of compound 2B analogues could be explored to develop anti-AD agents.

30 March 2022 in RSC Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
LLLuana Canzian Llanes
Luana Canzian Llanes
NSNathalia Biazotto Sa
Nathalia Biazotto Sa
ACArthur Ribeiro Cenci
Arthur Ribeiro Cenci
KTKerolain Faoro Teixeira
Kerolain Faoro Teixeira
IFIgor Vinícius de França
Igor Vinícius de França
AOAldo Oliveira
Aldo Oliveira
In this review we present the bioactive compounds of two classic potions: love potion and sleeping potion. This review also includes details on the presence of these bio-active molecules in current medicine and their effects.